Turn Therapeutics Inc. (TTRX)
Nasdaq: TTRX · Pharmaceutical Preparations · Westlake Village, CA · filing with the SEC since 2024
Who runs Turn Therapeutics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Burnam Bradley Evan
Chief Executive Officer. First filing Oct 2025, latest Jun 1, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
7 people on the record since 2025
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Burnam Bradley Evan | Chief Executive Officer | Oct 2025 | Jun 1, 2026 | none |
| Chaudhary Zuraiz | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | Oct 2025 | Apr 3, 2026 | none |
| Ghodadra Neilesh Shailesh | Chief Medical Officer | Oct 2025 | Oct 10, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dewhurst Martin William | director | Jan 2026 | Jun 8, 2026 | none |
| Gengos Andrew | director | Oct 2025 | Jun 8, 2026 | none |
| Golden Arthur F | director | Oct 2025 | Jun 8, 2026 | none |
| Kester Kent Edward | director | Oct 2025 | Jun 8, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Beb Holdings, LLC | 10% owner | Oct 2025 | Jun 1, 2026 | none |
| Chesed Abraham | other | Oct 2025 | Oct 29, 2025 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.